Education
About Us
Working with TipRanks
Follow Us
Andrew Saik Insider Profile
11 Followers
Andrew Saik, CFO at Auxilium, holds 204.27K shares in Arvinas Holding Company (Ticker: ARVN), holds 68.27K shares in Intercept Pharma (Ticker: ICPT), holds 116.47K shares in VYNE Therapeutics (Ticker: VYNE).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-52.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andrew Saik holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Saik
Andrew Saik's Trading History
Auxilium
Jan 30, 2015
―
Uninformative Sell
365.30K
―
PDS Biotechnology
Feb 19, 2020
CFO, Director
Uninformative Buy
49.92K
$28.38K
VYNE Therapeutics
Jun 02, 2021
CFO
Uninformative Buy
10.11K
$68.37K
Intercept Pharma
Sep 25, 2023
―
Uninformative Sell
9.81K
$1.30M
Arvinas Holding Company
Mar 02, 2026
CFO
Uninformative Buy
―
$2.73M
Milestone Pharmaceuticals
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Andrew Saik's performance on stock
You May Also Like
Andrew Saik insider profile FAQ
What is the percentage of profitable transactions made by Andrew Saik?
The percentage of profitable transactions made by Andrew Saik is 0%.
What is the average return per transaction made by Andrew Saik?
The average return per transaction made by Andrew Saik is -52.10%.
What stocks does Andrew Saik hold?
Andrew Saik holds: AUXL, PDSB, VYNE, ICPT, ARVN, MIST stocks.
What was Andrew Saik’s latest transaction?
Andrew Saik latest transaction was an Uninformative Buy of ―.
What was Andrew Saik's most profitable transaction?
Andrew Saik’s most profitable transaction was an Informative Sell of ARVN stock on February 18, 2026. The return on the trade was -12.20%.
What is Andrew Saik's role in Auxilium?
Andrew Saik's role in Auxilium is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.